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Abstract
Viral infection is a stimulus for apoptosis, and in order to sustain viral replication many viruses are known to carry genes
encoding apoptosis inhibitors. F1L, encoded by the orthopoxvirus modified vaccinia virus Ankara (MVA) has a Bcl-2-like
structure. An MVA mutant lacking F1L (MVADF1L) induces apoptosis, indicating that MVA infection activates and F1L
functions to inhibit the apoptotic pathway. In this study we investigated the events leading to apoptosis upon infection by
MVADF1L. Apoptosis largely proceeded through the pro-apoptotic Bcl-2 family protein Bak with some contribution from
Bax. Of the family of pro-apoptotic BH3-only proteins, only the loss of Noxa provided substantial protection, while the loss
of Bim had a minor effect. In mice, MVA preferentially infected macrophages and DCs in vivo. In both cell types wt MVA
induced apoptosis albeit more weakly than MVADF1L. The loss of Noxa had a significant protective effect in macrophages,
DC and primary lymphocytes, and the combined loss of Bim and Noxa provided strong protection. Noxa protein was
induced during infection, and the induction of Noxa protein and apoptosis induction required transcription factor IRF3 and
type I interferon signalling. We further observed that helicases RIG-I and MDA5 and their signalling adapter MAVS contribute
to Noxa induction and apoptosis in response to MVA infection. RNA isolated from MVA-infected cells induced Noxa
expression and apoptosis when transfected in the absence of viral infection. We thus here describe a pathway leading from
the detection of viral RNA during MVA infection by the cytosolic helicase-pathway, to the up-regulation of Noxa and
apoptosis via IRF3 and type I IFN signalling.
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Introduction
Cell death by apoptosis can protect a multicellular organism
against viral infection: if the first infected cell dies in time the
virus will not have the chance of producing new viral particles.
Many viruses counter this cellular response by carrying genes
coding for inhibitors of the host cell’s apoptosis machinery. This
interrelationship has first been shown clearly in a baculovirus
where the loss of the caspase-inhibitor p35 leads to cell death and
reduction in viral productivity [1]. Numerous viral anti-apoptotic
genes have by now been found, whose products often have
structural resemblance to mammalian anti-apoptotic proteins
[2,3].
A number of poxviruses carry, among other anti-apoptotic
genes, genes coding for proteins that resemble the inhibitory
members of the mammalian Bcl-2-family of proteins. These genes
have very little (if any) primary sequence homology with the
mammalian proteins but crystallization studies have shown that
they adopt a virtually identical structure. One critical feature of
anti-apoptotic function of Bcl-2-proteins is the existence of a
hydrophobic groove that accommodates the BH3-domain of pro-
apoptotic Bcl-2-family members and thereby inhibits apoptosis
[4].
Intriguingly, there is considerable variation at this critical
structural position in poxviral Bcl-2-related proteins. The M11L
protein from myxoma virus can bind BH3-domains with high
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affinity and cell biological studies indicate that the binding to pro-
apoptotic Bax and Bak (via their BH3-domains) is necessary for the
anti-apoptotic function of M11L [5]. Other poxviral proteins with
a Bcl-2-like fold (as determined in the crystal structure) lack the
structural hydrophobic groove and hence the ability to bind BH3-
domains, despite having the other structural features of Bcl-2 [6].
These proteins (and other, related poxvirus-encoded proteins)
seem to have functions in manipulating the host immune response
rather than in apoptosis prevention [7]. How these structures and
diverging functions have evolved is intriguing but unclear.
The F1L protein has been found to inhibit apoptosis in vaccinia
virus (VACV) as well as in the highly attenuated VACV strain
modified vaccinia virus Ankara (MVA) [8,9]. The crystal structure
of MVA F1L surprisingly showed that F1L protein dimerizes
through a helical domain swap and that it, although it can bind
some BH3-domain-peptides, does so with low affinity. Even the
binding to the BH3-domain of Bim, the pairing of F1L with the
highest affinity among all BH3-domains, occurs at a much lower
affinity than the binding of any BH3-domain to mammalian Bcl-2
proteins thought to be functionally relevant [10,11]. F1L protein
has further been identified as an inhibitor of caspase-9 [12].
Mammalian anti-apoptotic Bcl-2-like proteins (Bcl-2, Bcl-XL,
Bcl-W, Mcl-1, A1) can inhibit most forms of apoptosis, namely
those using the release of cytochrome c from mitochondria as a
signalling step. Cytochrome c is normally localised in the
mitochondrial intermembrane space. Once released to the cytosol
it initiates the formation of a big protein complex known as the
apoptosome; in the apoptosome caspases are activated [13].
The release of cytochrome c is achieved by the action of the
two pro-apoptotic effectors of the Bcl-2-family, Bax and Bak,
either one alone or both together. Bax/Bak in turn are activated
by one or several of the Bcl-2-family subclass of BH3-only
proteins (Bim, Bid, Puma, Noxa, Bmf, Bad, Bik, Hrk). The anti-
apoptotic Bcl-2-like proteins can bind (although with varying
affinity) both BH3-only proteins and Bax/Bak and probably
inhibit apoptosis by this direct binding; whether they inhibit
apoptosis preferentially by binding to BH3-only proteins or to
Bax/Bak is under dispute. The other BH3-only proteins very
likely others operate indirectly by inhibiting the suppressors (Bcl-2
and Bcl-2-like inhibitors) [4,14].
Given its anti-apoptotic function and Bcl-2-like structural fold
it is very likely that F1L also inhibits apoptosis by binding of
pro-apoptotic Bcl-2 family proteins. (VACV) F1L binding to
Bak (but not Bax) has been demonstrated in immuno-
precipitation experiments from infected cells [15,16] and this
interaction has been mapped within the protein [17]. It has also
been suggested that F1L directly binds Bim [18]. However, even
the combined inhibition of Bim and Bak is unlikely to explain
the profound inhibition of apoptosis in VACV- or MVA-
infected cells [8,9].
F1L-deficient VACV and MVA induce Bax/Bak-dependent
apoptosis in their host cells [9,17] suggesting that viral infection
activates BH3-only proteins, which then activate Bax/Bak. Bim
appears to play some role as Bim-deficient cells undergo slightly
less apoptosis than wt cells when infected with VACV-DF1L [18].
Bad has also been proposed to play a role in VACV detection as
MEK induced activation of Bad has been shown to be inhibited by
VACV secreted VGF protein [19]. The receptors that an infected
cell uses to detect the viral infection and that then activate the
apoptotic apparatus, and which components of the apoptotic
machinery (besides Bim) are involved in transmitting this signal are
unknown.
In this study we analysed these upstream signals. We found that
both Bim and (more importantly) Noxa were involved in the
induction of apoptosis by MVADF1L. Analysis of the upstream
signals suggested a contribution from the type 1 interferon (IFN)
signalling pathway in MVA-induced activation of the apoptotic
pathway.
Results
For these studies we used infection of various cell types and cells
from genetically modified mice for analysis with either wt MVA or
with the deletion mutant virus MVADF1L, which lacks the F1L
gene. Expression of the F1L protein in infected cells was detected
from 8 through to 48 h (Supplementary Figure S1). Upon
infection of mouse embryonic fibroblasts (MEFs), cell death was
first detectable around 8–12 h post-infection (Supplementary
Figure S2A). As reported earlier [9], infection with MVADF1L
induced apoptosis via the mitochondrial pathway. Mitochondrial
apoptosis depends on the activities of either Bax or Bak.
MVADF1L induced apoptosis was reduced in Bak-deficient MEFs
and abolished in Bax/Bak-double-deficient MEFs (Figure 1A,
Supplementary Figure S2B) much like it has previously been
reported for UV mediated apoptotic stress [20]. These results
suggest that infection with MVA mainly triggers Bak but in its
absence also Bax, whereas F1L blocks this process (similar results
have been reported previously for MVA by us [9] and for VACV
by others [15,16]).
Bax/Bak are activated by the action of BH3-only proteins. To
test the contribution of individual BH3-only proteins we tested
MEFs from mice deficient in individual BH3-only proteins for
differences in apoptosis when infected with MVADF1L. As shown
in Figure1B and Supplementary Figure S2C, the loss of Bim
conferred a small degree of protection; a similar effect has
previously been reported for VACVDF1L [18,19]. No protection
was seen by individual loss of Puma, Bid, Bad or Bmf (Figure 1D,
Supplementary Figure S2D) unlike previously reported for
VACVDF1L, where Bad-specific RNAi strongly inhibited apop-
tosis induced by infection of HeLa cells [19]. However, MEFs
deficient in Noxa were clearly protected against apoptosis induced
by infection with MVADF1L, and this effect was stronger than the
one seen in Bim-deficient cells (Figure 1C, D, Supplementary
Figure S2C).
Author Summary
Viruses have come up with a diverse set of mechanisms to
stop infected cells from committing suicide and hence
secure their own propagation. In this study we use the
DNA virus Modified Vaccinia virus Ankara, a highly
attenuated version Vaccinia Virus, to study how cells
detect viral infection and induce apoptosis. Modified
Vaccinia virus Ankara is currently in clinical trials for its
use in various vaccination protocols. By using a broad array
of immortalized and primary cell types we observed that
viral infection induced programmed cell death was
controlled by proteins predominantly involved in detec-
tion of viral RNA, in particular proteins involved in the type
1 interferon response. The novelty of our findings lies on
the observation that not only can RNA from DNA viruses
be detected and activate the type 1 interferon response to
infection, but that these responses can also directly
modulate the levels of proteins regulating programmed
cell death. Future treatments of infections by viral
pathogens could exploit the synergistic ability of the type
1 interferon responses and programmed cell death in
order to inhibit viral propagation.
RNA Mechanisms in DNA Virus Detection
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In earlier work we had found that there was no effect of the loss
of individual BH3-only proteins during infection with MVADF1L
(results mentioned as data not shown in [9]). We are unable to
retrace what it was that produced this incorrect result at the time.
Noxa protein is typically expressed only at low levels but is
induced by pro-apoptotic stimuli. We were unable to detect Noxa
protein in MEFs (which is most likely due to the low sensitivity of
antibodies against mouse Noxa by Western blot) and therefore
used the human epitheloid cell line HeLa to test for Bim and
Noxa-expression during MVA-infection. Bim protein levels
decreased within 20 h.p.i, perhaps explaining the observation that
Bim only plays a minor role during MVA or MVADF1L infection
(Figure 2A). Loss of Bim protein was also observed in MEFs upon
infection (data not shown). Infection with either MVA or
MVADF1L led to the induction of Noxa protein in HeLa cells,
beginning at about 4 h p. i. (Figure 2B). Expression of F1L
occurred with a similar time course (Supplementary Figure S1).
This suggests that the infection by MVA induces the expression of
Noxa, which is required for full induction of apoptosis, while F1L
inhibits Noxa-dependent apoptosis. Noxa and, to a lesser extent,
Bim are therefore triggers of apoptosis induced by MVADF1L.
Although these data indicate that F1L blocks Bim- and Noxa-
dependent apoptosis, it is not clear how this works on a molecular
level. It has been suggested that F1L directly binds to and inhibits
Bim [10,18]. We tested this hypothesis in two separate
experimental systems. In the first of those, membrane fractions
Figure 1. MVADF1L mediated apoptosis is predominantly induced by the BH3-only proteinNoxa. (A) wt, Bak2/2, Bax2/2, and Bax2/2/
Bak2/2MEFs were iinfected with MVA or MVADF1L (M.O.I = 10) for 20 h. Cell death was assessed by PI staining. UT, untreated (B) wt and Bim2/2MEFs
were infected as in A. (C) wt and Noxa2/2 MEFs were infected as in A. In parallel, aliquots from the same cell lines were treated with UV light (100 J/
m2) and incubated for 20 h. (D) wt, Bim2/2, Noxa2/2, Bmf2/2, Bad2/2, Bid2/2, and Puma2/2 MEFs were treated as in A. (* indicates statistical
significance (Student’s t-test, p#0.05 with data indicating mean/SEM of n$3).
doi:10.1371/journal.ppat.1002083.g001
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including intact mitochondria from uninfected control cells and
from cells infected with MVA (the latter containing F1L protein)
were incubated with a synthetic peptide comprising the Bim BH3-
domain (the active domain in BH3-only proteins). This leads to the
activation of Bax and Bak and the release of cytochrome c
[21,22,23]. In mitochondria isolated from control cells, Bim-
peptide caused substantial release of cytochrome c at concentra-
tions starting around 30 mM (similar to results from other studies,
Figure 2C). The release of cytochrome c from mitochondria from
MVA-infected cells, and hence expressing F1L, was achieved at
slightly higher concentrations of Bim peptide (less than a 2-fold)
(Figure 2C).
In the second experimental setting, we used a MEF cell line
where BimS (the most active splice form of Bim) is placed under
the control of a tetracycline-inducible promoter. Addition of
tetracycline to the culture medium induces Bim in these cells and
causes rapid apoptosis (Supplementary Figure S3A, B). Prior
infection with MVA for 8 h, to ensure F1L expression, again had
only a very small protective effect in this system (Figure 2D,
Supplementary Figure S3A, C). While overexpression of Bims is
not reduced during MVA infection, endogenous Bim (BimEL)
levels appear to be lower in MVA infected cells, as observed in
Helas (Supplementary Figure S3B, Figure 2A). These results
suggest that direct binding of F1L to Bim, which can occur with
Figure 2. MVA infection causes a reduction in Bim levels and induction of Noxa expression while F1L weakly inhibits Bim induced
apoptosis. (A) HeLa cells were treated with staurosporine (1 mM) for 8 h or infected with MVA or MVADF1L (M.O.I = 10) for 20 h and Bim levels were
assessed by Western blotting (x represents protein of unknown origin). (B) HeLa cells were infected with MVA or MVADF1L (M.O.I = 10) for the
indicated times and Noxa levels were assessed by Western blotting. (C) Digitonin (0.025% w/v) permeabilizedcells from uninfected or MVA infected
MEFs (8 h p.i) were treated with the indicated concentrations of Bim BH3 peptide to detect cytochrome c release by Western blot. C corresponds to
the cytosolic fraction released upon cellular membrane permeabilization. S corresponds to the supernantant fraction after Bim-BH3-peptide
treatment of permeabilised cells. P represents the pellet fraction including nucleus, cellular membrane and intact or treatment-permeabilized
mitochondria. (D) MEFs carrying tetracyclin inducible Bims were infected with MVA or MVADF1L for 8 h before addition of tetracycline (0.1 mg/ml) for
12 h. Apoptosis was assessed by PI staining (* indicates statistical significance according to the student’s t-test, p#0.05 with data indicating mean/
SEM of n$3; x indicates unspecific band).
doi:10.1371/journal.ppat.1002083.g002
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low affinity [10], plays only a minor role in the protection against
virus induced apoptosis by F1L in these cells.
Cell lines and MEFs are versatile tools for the analysis of MVA-
infection in vitro but are not the natural host cells of MVA-infection
in vivo. Infection of mice with a recombinant MVA driving the
expression of GFP in infected cells showed that upon intravenous
infection especially macrophages and dendritic cells (DCs) and to a
lesser extent lymphocytes were infected in the spleen (Figure 3A;
Supplementary Figure S4 shows results at a 10-fold higher dosage
of virus). We therefore undertook an analysis of the apoptotic
response of these host cells to infection with MVA or MVADF1L.
Mouse myeloid macrophages and DCs were differentiated
from bone marrow. DCs differ from epithelial cells and
fibroblasts in that they undergo apoptosis upon infection with
wt MVA [24,25]. We found substantial induction of apoptosis in
both macrophages and DCs upon infection with MVA (Figure 3B,
C). However, apoptosis induced by MVADF1L was much faster
and reached higher levels over 48 h (Figure 3B, C). As we had
found for fibroblasts, the loss of Bim gave small protection against
apoptosis induced by MVA or by MVADF1L in both cell types
(Figure 3B, C).
We then tested apoptosis induction in macrophages, DCs,
activated T-cells and B cells isolated from wt, Bim-, Noxa- or Bim/
Noxa-deficient mice. MVADF1L induced substantial apoptosis in
all these cell types while MVA-induced apoptosis reached higher
levels only in the two myeloid cell types (DC, macrophages) but
not in lymphocytes (Figure 4, Supplementary Figure S5 and S6).
There were small differences in the pattern of apoptosis-sensitivity
in the various cell types. The protection against MVADF1L
induced apoptosis by the loss of Bim was minimal in myeloid but
more clearly detectable in lymphoid cells. Single loss of Noxa
provided moderate protection in all cell types, and the combined
loss of Bim and Noxa protected not completely but very strongly
against apoptosis induced by MVADF1L infection in all cells
analysed (Figure 4, S5, S6).
To ensure that the decrease in apoptosis observed due to loss of
Bim and to a greater extent loss of Noxa was not specific for
mouse, we tested the role of BH3-only proteins in HeLa cells by
RNAi. siRNAs directed against Bim, Puma or Noxa were
transfected into HeLa cells prior to infection, alone or in
combination. As shown in Figure S6, there was no detectable
protection by knock-down of Bim, Puma or the combination of
Bim and Puma. However, Noxa-specific RNAi strongly reduced
apoptosis induced by MVADF1L infection and inhibited the
strong induction of Noxa induced by MVADF1L infection in these
cells (Supplementary Figure S7B, lanes 3, 5 and 8). The
combination of Bim- and Noxa-knock-down failed to give more
protection than RNAi against Noxa alone, suggesting that Bim
played only a very minor role in these cells, as previously reported
for VACVDF1L [19].
These data suggested that the induction of Noxa protein upon
infection with MVADF1L was a major triggering event of
apoptosis. Noxa was originally identified as a p53 transcriptional
target. However, macrophages lacking expression of p53 did not
show a significant decrease in apoptosis in response to MVA or
MVADF1L (Supplementary Figure S8A). Subsequent work has
shown that the Noxa promoter is also regulated by a CreB binding
site and an interferon-stimulated responsive element (ISRE) [26],
and that Noxa is induced by IFN I. INFb was clearly induced
during MVA and MVADF1L infection (Supplementary Figure
S8B), as was IL-18, a cytokine whose secretion is regulated
through the inflammasome (Supplementary Figure S8C). Howev-
er, loss of the inflammasome activity by ASC deficiency had no
effect on the apoptotic response of macrophages to MVA or
MVADF1L (Supplementary Figure S8D). Since IFN I are induced
during MVA and MVADF1L infection within 8 h we focussed on
the investigation of this system and its role in Noxa-induction and
apoptosis during infection with MVADF1L.
We first isolated and tested macrophages from mice deficient in
various interferon responsive factors (IRFs; transcription factors
involved in the regulation of IFN and IFN-responsive genes).
There was significant protection against apoptosis induced by
either MVA or MVADF1L by the combined loss of IRF-1 and -3
or IRF-1, -3 and -7 but not the loss of IRF-1 or IRF-1 and -7
(Figure 5A, S6B; mice deficient only in IRF-3 were not available to
us). IRF-3 is therefore required for the full induction of apoptosis
by infection with MVA/MVADF1L.
IRF-3 is activated by signalling pathways that can be triggered
by the recognition of viral molecules. In particular, viral nucleic
acids can be recognized by a number of receptors including
protein kinase R (PKR; recognizing double stranded RNA),
cytosolic helicases (RIG-I, MDA5; recognizing free 59-triphos-
phates and double stranded RNA, respectively) and Toll-like
receptors (TLR).
We first tested MEFs from mice deficient in protein kinase R
(PKR) but found no protection while MEFs double deficient in
IRF-3 and -7 were significantly protected (Figure 5B). We also
tested macrophages deficient in MyD88 (a major adaptor
molecule in the Toll-like receptor signalling pathway) and
observed that there was no protection in response to MVA or
MVADF1L induced apoptosis (Supplementary Figure S8D).
We then turned to the analysis of the signalling pathways that
induce Noxa-promoter activity. A luciferase reporter construct
containing either 1.2 kb Noxa promoter-sequence (carrying an
ISRE and bindings sites for p53 and creB), or the same sequence
lacking the binding sites for creB and IRFs [26] were transfected
into MEFs from mice with various gene deletions. These cells were
then either treated with etoposide (known to induce Noxa via p53)
or infected with MVA or MVADF1L.
Etoposide induced Noxa-promoter activity in cells from all
genotypes tested and this induction was similar in the cases of the
intact and mutant promoters (which still contains the p53
recognition site), consistent with the p53-dependent induction of
Noxa by etoposide (Figure 5C). The induction of Noxa-promoter
activity by infection with MVA or MVADF1L, however, was
almost abrogated by the promoter deletions (Figure 5C). This
indicates that the Noxa induction is almost completely achieved
via the IFN I system.
The activity of the intact promoter upon infection was normal
in IRF-1-deficient cells but strongly diminished in cells deficient in
IRF-3 and -7, again consistent with an important role of IRF-3 in
virus-induced up-regulation of Noxa. When we tested cells
deficient in the mitochondrial helicase adapter MAVS (also
known as IPS-1, VISA or CARDIF) we also found a significant
reduction in Noxa-promoter induction upon infection with MVA
or MVADF1L (Figure 5C).
These data suggested that the pathway to apoptosis induction
involved the signalling axis from cytosolic helicases, their
mitochondrial adapter MAVS and the transcription factor IRF3.
MEFs from mice lacking MAVS were significantly protected
against MVADF1L induced apoptosis, consistent with the MAVS-
dependent induction of Noxa-promoter activity observed in the
experiments described above (Figure 6A). Mouse Noxa protein is
difficult to detect with the antibodies available. We were able to
detect Noxa-induction upon infection with MVA in the presence
of the proteasome inhibitor MG-132. No Noxa was detectable
upon infection of MAVS-deficient MEFs (Figure 6B). A MAVS-
dependent signal is thus induced upon infection with MVA
RNA Mechanisms in DNA Virus Detection
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Figure 3. Infection pattern and effect of the loss of Bim in primary haematopoietic cells upon infection of mice with MVA. (A) Mice (n
= 3) were infected i.v. with 36108 IU of MVA-GFP for 3 hours before spleens were harvested. Splenocytes were stained and cell populations were
identified as follows: macrophages (MHC II high /CD11c intermediate / CD11b high), dendritic cells (MHC II high /CD11c high), B cells (MHC II high-
intermediate /CD45R (B220) high), granuloytes (Gr-1 high / CD11b high), T cells (CD3+). Dot blots show the gating strategy for macrophages and
dendritic cells from total splenocytes. Histogramgives the relative distribution of the different cell types within the total number of MVA-infected
(GFP+) cells. (B) wt and Bim2/2 M-CSF bone marrow derived macrophages were infected with MVA or MVADF1L at an M.O.I of 10 for the indicated
times. Cell death was assessed by PI staining. (C) wt and Bim2/2 M-CSF bone marrow derived macrophages or GM-CSF bone marrow derived
dendritic cells where infected as in B for 20 h p.i. UT, untreated (* indicates statistical significance according to the student’s t-test, p#0.05 with data
showing mean/SEM of n$3).
doi:10.1371/journal.ppat.1002083.g003
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orMVADF1L, which causes the IRF-3-dependent up-regulation of
Noxa and apoptosis.
One of the primary functions of this pathway is the induction of
type 1 interferons [27]. INF-b secretion can be detected in the
supernatant of MVA or MVADF1L infected macrophages
(Supplementary Figure S8B) (this has been reported for MVA
previously [28,29]. IFN-b often serves to amplify an IRF-
dependent response. We therefore tested the effect of IFNb
signalling on apoptosis induced by MVA or MVADF1L. INFb-
secretion was induced to a similar extent by infection with MVA
or MVADF1L (Supplementary Figure S8B). When IFN-b-
signalling was disrupted by the use of macrophages from mice
deficient in the IFN I receptor (IFNAR) there was again protection
against apoptosis induced by viral infection to a similar extent as
by the loss of Noxa or IRF-3 (Figure 6C and D).
However, disruption of IFN-b-signalling failed to inhibit IRF-3
translocation to the nucleus in response to MVA infection in HeLa
cells (transfected with siRNA against IFNAR) or macrophages
(from IFNAR-deficient mice) (Supplementary Figure S9A, S9D
and S9E). IRF-3 translocation to the nucleus was slightly slower in
HeLa cells transfected with IFNAR-specific siRNA (Supplemen-
tary Figure S9A, and S9B), concurrent with reduced apoptosis of
HeLa cells treated with siRNA to IFNAR (Supplementary Figure
S9C). No differences were detectable by analysis of IFNAR-
translocation by Western blot of cytosolic and nuclear fractions in
either cell type (Supplementary Figure S9D, E). The activation of
IRF-3 is therefore probably insufficient for induction of Noxa; this
latter step likely requires IFN-signalling through Stat proteins.
NF-kB, which is activated by MAVS and can contribute to IFN
I-signalling did not appear to play a role in the induction of Noxa
as no NF-kB activity was induced by viral infection (Figure 6E).
Viral infection also failed to increase the NF-kB response to
extrinsically added IL-1 (there was even some reduction, which
may be due to the expression of a functional soluble IL-1-receptor
by MVA [30], Figure 6E).
These results show that MVA- and MVADF1L-infection
induces apoptosis dependent on the signalling adapter MAVS,
the transcription factor IRF-3, IFN-b and the BH3-only protein
Noxa. We then turned to HeLa cells, on one hand to confirm these
results in another cell type and on the other hand to test the role of
the helicases upstream of MAVS by RNAi. The individual genes
were knocked down by transfection of siRNA, and the cells were
infected with MVA or MVADF1L. No apoptosis induction by
MVA was seen as expected (Figure 7A). RNAi directed against
IFNAR, IRF3 or MAVS all substantially reduced apoptosis
induced by MVADF1L as well as the induction of Noxa by MVA
(Figure 7A). Mixed RNAi against both IRF3 and IFNAR showed
a slightly enhanced effect. Recognition and apoptosis pathways
therefore appear to be similar in mouse and human cells.
MAVS is the signalling adapter of two helicases, RIG-I and
MDA5, which recognise viral RNA-species [27]. This signalling
system has been very well characterised for RNA-viruses and
although it is generally assumed that similar receptors exist for
viral DNA the only receptor universally accepted drives the
activation of the inflammasome rather than of the type 1
interferon signalling [31].
However, viral RNA produced during infection with a DNA-
virus like MVA may still be recognised by the helicase machinery,
and evidence has recently been reported that MVA can be
recognised by MDA5 [28]. It has also been described that MVA
induces the formation of viral dsRNA in the cytosol post RNA
secretion from the viral particle [32]. Indeed, RNAi against
MDA5 and to a slightly lesser extent against RIG-I provided
protection against apoptosis induced by MVADF1L, concomitant
with the diminished induction of Noxa protein (Figure 7A).
This suggested that indeed viral RNA, generated during MVA
infection, is recognised by these helicases to signal through MAVS
for the induction of Noxa. Although we saw no protection by
transfection of a RIG-I helicase fragment (RIG-IC; constructed as
a dominant negative inhibitor of RIG-I-signalling [33]), the
Figure 4. Contributions of Noxa and Bim to apoptosis induced by MVA and MVADF1L in primary MVA target cells. M-CSF bone
marrow derived macrophages and GM-CSF bone marrow derived dendritic cells, B220+ MACS sorted B-cells and NK1.12/B2202/MHCII2 MACS sorted
ConA activated T-cells were infected with MVA or MVADF1L at an M.O.I of 10 for 20 h. Cell death was assessed by PI staining and relative numbers
were calculated by calculating the % increase in PI proportional to the untreated sample with the following equation: (((% treated PI+)2(% untreated
PI+))/% untreated PI+*100). (* indicates statistical significance according to the student’s t-test, p#0.05; with data giving mean/SEM of n$3).
doi:10.1371/journal.ppat.1002083.g004
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inhibitory helicase-like molecule LGP2 [34] reduced apoptosis
induced by MVADF1L (Supplementary Figure S10A). More
importantly, overexpression of LGP2 but not RIG-I or RIG-IC
led to an increase of FLAG expressing attached (viable) cells after
infection with MVADF1L indicating protection of transfected cells
against apoptosis induction by MVADF1L (Supplementary Figure
S10B). This suggested that it is the viral RNA produced during
infection with MVA that is recognised and that triggers the
activation of the apoptotic pathway.
To test this hypothesis we performed experiments with virus
treated with UV-light. Complete cross-linking of the viral genome
by UV-treatment results in VACV or MVA that can still infect
cells but cannot efficiently generate viral RNA [35]. UV-treated
MVA or MVADF1L failed to induce apoptosis in HeLa cells
(Figure 7B). Lack of apoptosis by UV-treated MVADF1L
correlated with lack of Noxa induction (data not shown). We
then infected cells with MVA or MVADF1L and isolated total
RNA; this RNA contains host cell and viral RNA in the case of
untreated virus but only host cell RNA when isolated from cells
that remained un-infected or had been infected with UV-treated
virus. When this RNA was transfected into uninfected HeLa cells,
it induced substantial apoptosis (to about the same extent as
Figure 5. A, B, MVA induced apoptosis requires IRF-3 but not IRF-1, -7 or PKR. (A) wt, IRF-12/2, IRF-12/232/2, IRF-12/272/2 and
IRF-12/232/272/2M-CSF bone marrow derived macrophages were infected with MVA or MVADF1L at an M.O.I of 10 for 20 h. Cell death was assessed
by PI staining and relative numbers were calculated by calculating the % increase in PI proportional to the untreated sample as in Figure 4. (B) wt,
PKR2/2, IRF-12/2 and IRF-32/272/2 MEFs were infected as in A. Cell death was assessed by PI staining. UT, untreated. (C) Infection with MVA or
MVADF1L induces Noxa-promoter activity through IRF-3. wt, IRF-12/2, IRF-32/272/2 and MAVS2/2 MEFs were transfected with the reporter
constructs of the NOXA promoter (pGL3-basic plasmid carrying wt or a double mutant (deletion of the CreB and IRE sites) Noxa 1.2 kb promoter
region). 24 h after transfection cells were split onto a 96 well plate. The next day aliquot wells were treated with etoposide (10 mM) or infected with
MVA or MVADF1L (M.O.I = 10). 8 h later, luciferase activity was measured and the index of induction was calculated from the ratio of the luciferase
activity in treated cells divided by the luciferase activity in untreated cells. (* indicates significance according to the student’s t-test, p#0.05 with data
giving mean/SEM of n$3).
doi:10.1371/journal.ppat.1002083.g005
RNA Mechanisms in DNA Virus Detection
PLoS Pathogens | www.plospathogens.org 8 June 2011 | Volume 7 | Issue 6 | e1002083
Figure 6. IRF3 induced activation of Noxa is dependent on MAVS and IFN-I-signaling. (A) wt and MAVS2/2 MEFs were infected with MVA
or MVADF1L at an M.O.I of 10 for 20 h. Cell death was assessed by PI staining. (B) Cells were infected as in A but 16 hp.i cells remained untreated or
were treated with MG-132 (40 mM) for a further 4 h. Mouse Noxa (mNoxa) was detected by Western blot. (C) wt and IFNAR2/2 M-CSF bone marrow
derived macrophages were infected with MVA or MVADF1L at an M.O.I of 10 for 20 h. Cell death was assessed by PI staining. (D) wt, IFNAR2/2,
IRF-12/2, IRF-12/232/2, IRF-12/272/2 and IRF-12/232/272/2 M-CSF bone marrow derived macrophages were infected with MVA or MVADF1L at an
M.O.I of 10 for 20 h. Cell death was assessed by PI staining and relative numbers were calculated by calculating the % increase in PI proportional to
the untreated sample as in Figure 4. (E) T-REx 293 cells stably carrying a kB promoter luciferase reporter were infected with MVA or MVADF1L at an
M.O.I of 10 for 8 h. 4 hp.i cells were treated with IL-1b (10 ng/ml). Luciferase activity was determined and the index of induction was calculated from
the ratio of luciferase activity in treated cells divided by luciferase activity in untreated cells. (* indicates significance according to the student’s t-test,
p#0.05 with data showing mean/SEM of n$3).
doi:10.1371/journal.ppat.1002083.g006
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Figure 7. MVA-derived RNA is capable of inducing Noxa and apoptosis. (A) HeLa cells were transfected with the indicated siRNA 24 h prior
to infection with MVA or MVADF1L at an M.O.I of 10 for 20 h. Cell death was assessed by PI staining. MVA infected HeLa cells were further assessed
for Noxa levels by Western blotting. (B) MVA or MVADF1L (36106 IU) were resuspended in 1 ml medium and treated with 1 mg/ml of psoralen (4 -
aminomethyl-trioxsalen) and then irradiated with UV light for 15 min. Untreated or treated MVA or MVADF1L was then used to infect HeLa cells at an
M.O.I of 10 for 20 h. Cell death was assessed by PI staining. (C) Black Bars: total RNA from HeLa cells infected with UV treated or untreated (UT) MVA or
MVADF1L (or uninfected HeLa cells) (2 mg), poly (I:C) (10 mg) or pppRNA (1 mg) was transfected using Fugene reagent into HeLa cells. Cell death was
assessed 24 h later by PI staining and relative numbers were calculated by calculating the % increase in PI proportional to the Fugene-alone treated
sample with the following equation: (((% RNA+Fugene Treated PI+)2(% Fugene Treated PI+))/(1002% Fugene Treated PI+)*100). Grey bars: HeLa cells
were infected with MVA or MVADF1L at an M.O.I of 10 for 20 h. Cell death was assessed by PI staining and relative numbers were calculated by
calculating the % increase in PI proportional to the untreated sample as in Figure 4. (D) HeLa cells from C were further assessed for Noxa levels by
Western blotting. (* indicates significance according to the student’s t-test, p#0.05 with data showing mean/SEM of n$3).
doi:10.1371/journal.ppat.1002083.g007
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transfected poly I:C or 39-triphosphate RNA) while RNA
extracted from cells infected with UV-treated virus (containing
no viral RNA) had no pro-apoptotic effect (Figure 7C).
Viral RNA mediated induction of apoptosis correlated with the
induction of Noxa protein (Figure 7D) and was inhibited in HeLa
cells carrying Noxa-specific shRNA (Supplementary Figure
S11B).HeLa cells transfected with siRNAspecific for MAVS,
IRF-3, MDA-5, or IFNAR also showed decreased apoptosis when
transfected with RNA from infected cells (Supplementary Figure
S11B). This supports the hypothesis that viral RNA, produced
during infection with MVA, is the active component in terms of
apoptosis induction upon virus recognition.
Discussion
In this study we provide evidence that MVA triggers apoptosis
in host cells upon the recognition of viral RNA by host cell
helicases. This signalling utilises the known pathway encompassing
cytosolic helicases, the mitochondrial adapter MAVS, the type 1
interferon signalling machinery and the induction of the BH3-only
protein Noxa. Bim makes a small contribution, and F1L can
inhibit apoptosis pathways triggered by MVA.
How Bcl-2-family members interact to induce or to inhibit
apoptosis is still not entirely clear. Bim-induced apoptosis is often
linked to transcriptional induction of Bim, especially in the
immune system [4]. There was no induction but a small decrease
of Bim protein during MVA-infection. The role of Bim may
therefore in this case lie more in the steady state inhibition of anti-
apoptotic Bcl-2 proteins, which may lower the general threshold of
apoptosis induction and account for the relatively mild protective
effect of Bim-loss on apoptosis induction by MVADF1L. This
interpretation is also in accordance with our finding that F1L (as
expressed during infection) provides very little protection against
direct expression of Bim or the effect of the Bim BH3-peptide.
Other BH3-only proteins did not seem to make major
contributions, as suggested by the lack of protection by their
individual loss and by the strong protection by combined loss of
Bim and Noxa. This protection was however incomplete while the
combined loss of Bax and Bak provided complete protection.
Therefore, other BH3-only proteins may make minor contributions
that are too small to be apparent when the BH3-only protein is
deleted on its own. Alternatively, there may be BH3-only
independent activation of Bax/Bak. How this could occur is unclear
but it has been demonstrated for heat shock [36], and it is conceivable
that viral infection causes a sufficiently strong disturbance of cellular
systems to bring about such a (still relatively minor) effect.
Upon infection of mice MVA preferentially infects macrophages
and DC although T and B cells are also infected. Lymphocyte
apoptosis is to a large extent regulated by Bim [37] and it is
therefore not surprising that loss of Bim had the strongest
protective effect in lymphocytes. The combined role of Bim and
Noxa was apparent in all cell types tested. The main difference was
that MVA induced substantial apoptosis in macrophages and DC
but little in lymphocytes and none in fibroblasts and epithelial
cells. The simplest explanation for this would be different
expression levels of pro-apoptotic proteins in different cell types.
It has to be pointed out that it is still uncertain how F1L
functions molecularly. However relevant the detectable binding to
Bak and to Bim may be (shown for VACV F1L), this is not
sufficient to explain the complete protection observed during
infection. It has recently been suggested that VACV F1L acts like
Mcl-1 [38]. Although this may be the case in the circumstance of
viral infection, Mcl-1 has a much broader activity in terms of
binding specificity for pro-apoptotic Bcl-2 family proteins.
Noxa is required for full apoptosis in cells infected with
MVADF1L, and F1L therefore very likely interferes with Noxa-
dependent apoptosis. Since the Noxa BH3-domain does not bind
to F1L with significant avidity [10] it seems unlikely that F1L
binds Noxa directly. Noxa may inactivate Mcl-1, releasing Bak,
which is then inhibited by F1L. An additional function of F1L has
recently been reported, namely the direct inhibition of caspase-9
[12], and this mechanism may add to the anti-apoptotic effect of
MVA-infection.
The earliest components of the apoptotic pathway are therefore
the BH3-only proteins Bim and Noxa. The activity of Noxa is
linked to its transcriptional induction [39]. Although viral
replication blocks cellular transcription, the infected cell still
appears to have the time to induce Noxa protein. The induction of
Noxa follows a pathway that, with some variations, has been
described in other situations. RIG-I/MDA5 signal through MAVS
to activate IRFs, which induce IFN-b [27]. IRF-3 may directly
induce Noxa-expression, and the amplifying effect of IFN-b may
be through increased IRF-3 expression [28]. Alternatively, IFN-b
may induce Noxa; this is suggested by the requirement of IFN I-
signalling for full apoptosis induction in cells infected with
MVADF1L. In melanoma cells, the activation of RIG-I or
MDA5 by transfection of 39-triphosphate RNA or poly I:C,
respectively, caused Noxa-induction and Noxa-dependent apop-
tosis without additional type 1 interferon signalling [40] while
during MVA-infection this feedback, probably signalling through
Stat-proteins, appears to be necessary.
Not only (RNA-recognising) helicases can induce apoptosis but
also TLR3 (using a mitochondria-independent pathway) [41],
which also recognises viral (double-stranded) RNA. Intriguingly,
the DNA-recognising TLR, TLR9 does not have this potential
(nor do the RNA-receptors TLR7/8). It is intriguing to observe
that even a DNA virus is recognised by RNA-sensors to induce
apoptosis. It has been demonstrated recently that MVA-infection
of macrophages leads to MDA5-dependent production of IFN-b
while RNAi to RIG-I had no effect on IFN-b-production [28].
Our results suggest that RIG-I also makes some contribution;
perhaps there is some cell-to-cell variation, or a different time
course of involvement of the two helicases that makes apoptosis-
induction more dependent on RIG-I than IFN-b-induction.
Recent work shows that RIG-I can recognise RNA transcribed
from DNA by RNA polymerase III [42,43], and such a
mechanism could operate for DNA-viruses. MDA5 probably
mainly recognises double-stranded RNA [44], and the recognition
by MDA5 may be limited to some DNA-viruses that, like
Poxviruses, generate dsRNA-intermediates due to overlapping
reading frames [32]. But since all viruses at some stage will
synthesise RNA, this is clearly the more general infection-
associated molecule than DNA, and to focus on RNA as
recognition molecule for viruses makes sense.
Apoptosis is one of the defence mechanisms against viruses.
Viruses pre-date the evolution of metazoan apoptosis, and it is
certainly conceivable that viral infection was one of the driving
forces in the evolution of the apoptotic apparatus. As an essentially
cell-autonomous defence system, apoptosis does not require
cellular specialisation. In a complex organism like the human,
apoptosis is very likely one of several defence mechanisms but may
well contribute to host defence against microbial infection.
Materials and Methods
Ethics statement
Animal experiments were conducted according to the legal
framework in Germany (as set by federal law in the ‘German
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Animal Protection Act’ (Tierschutzgesetz)) and had been approved
by the regional authorities (Regierung von Oberbayern; permit
number:211-2531-6-8/99) following the regular procedures of
application and approval.
Cells and viruses
wt (3T3), wt(SV40) , Bak2/2(SV40), Bax2/2(SV40), Bak2/2
Bax2/2(SV40), Bim2/2(3T3), Puma2/2(SV40), Noxa2/2(3T3),
Bid2/2(3T3), Bad2/2(3T3), PKR2/2 (3T3), IRF-12/2 (3T3),
IRF-32/272/2 (3T3), MAVS2/2 (SV40), MEFs were grown in
Dulbecco’s Modified Eagle Medium (DMEM), supplemented with
10% fetal calf serum, 1% Penicillin /Streptomycin, and 55 mM 2-
mercaptoethanol. (MAVS2/2 were kindly provided by Zhijian J.
Chen, Dallas).HeLa cells were grown in DMEM, 10%FCS,
1%Penicillin /Streptomycin. wt TetBims MEFs and T-REx 293
cells stably carrying a kB promoter luciferase reporter were
cultured in DMEM, 10%FCS (tetracycline-negative; PPA labora-
tories), 1%Penicillin /Streptomycin supplemented with 5 mg/ml
blasticidin and 125 mg/ml zeocin. Macrophages and Dendritic
Cells were differentiated (7 days) and maintained in RPMI,
10%FCS, 1%Penicillin /Streptomycin, 55 mM 2-mercaptoetha-
nol, supplemented with 10% M-CSF or GM-CSF enriched
medium obtained from the supernatant of LCCM Hybridomas
or B16 cells in the same medium, respectively. T-cells were
cultured and activated in RPMI, 10%FCS, 1%Penicillin/Strep-
tomycin, 55 mM 2-mercaptoethanol, supplemented with 1%
glutamine and Con A (2 mg/ml; Amersham Pharmacia Biosci-
ence). B cells were cultured in OPTI-MEM I+GlutaMAX-I,
10%FCS, 1%Penicillin /Streptomycin, 55 mM 2-mercaptoetha-
nol. ER-Hox B8 wt and IFNAR2/2 cells were cultured in RPMI,
10% FCS, 1%Penicillin /Streptomycin, 55 mM 2-mercaptoetha-
nol, supplemented with 1% GM-CSF enriched medium and 1 mM
bestridiol (Sigma). Differentiation was achieved by washing cells
and culturing them in RPMI, 10%FCS, 1%Penicillin /Strepto-
mycin, 55 mM 2-mercaptoethanol, supplemented with 10% GM-
CSF enriched medium.
shHela cells were generated by retroviral infection with
lentivirus driving shRNA against luciferase (59-GUGCGCUG-
CUGGUGCCAAC-39) and Noxa (5-GAAGGTGCATT-
CATGGGTG-3) in a GFP expressing lentiviral vector pLVTHM.
Lentiviralparticles were generated by transfecting 293FT cells
together with the packaging vectors pMD2.G and psPAX2.
Surviving cells were grown and collected and sorted to produce
polyclonal GFP+ populations as reported earlier [45].
Chicken embryonic fibroblasts (CEF) were prepared freshly
from 10 day old embryos, cultured in Earl’s minimum essential
medium and used in the second passage. MVA and MVADF1L
were routinely propagated and tittered by vaccinia virus-specific
immunostaining on CEF. Viruses were purified by ultracentrifu-
gation through sucrose and virus stocks were maintained at
280uC in aliquots containing $ 26108 IU/ml [46].
MVA expressing the enhanced green-fluorescence gene under
control of the VV natural early/late promoter P7.5 (MVA-GFP)
has been described previously [47]. MVA viruses were propagated
and titrated by following standard methodology [46].
Antibodies for Western blotting
Antibodies used for Western blot were specific for h/mBim,
Bad, Puma (Cell Signalling) hNoxa (Alexis), Bid (polyclonal rabbit
anti-Bid was kindly provided by David Huang, Melbourne) b-
actin, b-tubulin (Sigma), F1L (polyclonal rabbit anti-F1L was
kindly provided by Antonio Postigo and Michael Way, London),
Bak (NT; Upstate), cytochrome c, hMcl-1 (BD Pharmingen),
mNoxa, mIL-18 (Abcam), H3L (Polyclonal antiserum specific for
VACV H3 was generated by repeated immunization of a rabbit
using a synthetic peptide representing amino acids 247–259 within
the H3 protein as a conjugate to keyhole limpet hemocyanin
described by others [48]), GAPDH (Millipore), IRF3 (Santa Cruz
Biotechnology) Caspase-8 (Cell Signalling), Bak (4B5, kindly
provided by Ruth Kluck, Melbourne).
Cellular preparation
Spleen single cell suspensions from wt, Bim2/2, Noxa2/2, and
Bim2/2Noxa2/2 mice (all C57BL/6 background) were resus-
pended in Amonium chloride lysis buffer (150 mM NH4Cl,
10 mM NaHCO3, 1 mM Na2EDTA pH=7,4 ) for 5 min and
then washed in PBS. Cells were then further resuspendedin sorting
buffer (PBS, 0.5%BSA), washed and were labelled with anti-B220-
FITC (BD Pharmingen), FITC-anti-NK 1.1 (BD Pharmingen),
and anti-MHCII-FITC (BD Pharmingen) antibodies for 30 min at
4uC. Labelled cells were washed and resuspended with anti-FITC
micro beads (MiltenyiBiotec, Auburn, CA) for 30 min at 4uC.
Labelled cells were removed on MACS columns (MiltenyiBiotec,
Auburn, CA) in order to obtain T cell populations. To check
purity cells were stained with CD3-APC antibody (Purity $ 90%).
Cells were activated with ConA (2 mg/ml) for 3 days and split for
infection.
Splenocytes from mice of the genotypes above were resus-
pended in PBS, washed and were labelled with anti-B220 micro
beads (MiltenyiBiotec, Auburn, CA) for 30 min at 4uC or with
FITC-anti-B220 and treated as above. Labelled cells were purified
on MACS columns (MiltenyiBiotec, Auburn, CA). Dendritic cells
from wt, Bim2/2, Noxa2/2, Bim2/2Noxa2/2, IRF-12/2,
IRF12/232/2, IRF-12/272/2, IRF-12/232/272/2 and IF-
NAR2/2 mice (all C57BL/6 background) were derived from
bone marrow single cell suspensions cultured with enriched GM-
CSF medium for 7 days. On day 1 after isolation cells were
passaged to separate them from attached fibroblasts. Medium was
further enriched with GM-CSF on day 3. Floating cells were
collected and split for treatment on day 7. Macrophages were
isolated in the same way but with enriched M-CSF and attached
cells were used for infection on day 7.
Bim2/2, Noxa2/2, Bim2/2Noxa2/2 mice were kindly pro-
vided by Claire Scott, Philippe Bouillet or Andreas Strasser,
Melbourne. p532/2 mice were kindly provided by David Huang,
Melbourne. IRF-12/2, IRF-12/232/2, IRF-12/272/2 mice
were kindly provided by Hermann Wagner, Munich. IFNAR2/2
and IRF-12/232/272/2 mice were kindly provided by Admar-
Verschoor, Munich.
Death assays and treatments
Cell death was induced by treatment with MVA or MVADF1L
(M.O.I = 10) in DMEM medium 2%FCS enriched to 10% FCS
8 h.p.i for 20 h, ultra violet radiation (UV,100 J/m2) 20 h,
etoposide (10 mM, Sigma) 20 h, or staurosporine (1 mM) 8 h. In
the indicated experiments cells were exposed to MG-132 (40 mM)
for 4 h, 16 h.p.i. Floating cells and trypsinised attached cells were
combined and incubated in PBS containing 50 mg/ml propidium
iodide (PI) for 5 min on ice before measuring PI uptake by flow
cytometry.
Alternatively floating cells and trypsinised attached cells were
combined and incubated in 3.7% paraformaldehyde for 20 min at
room temperature, washed three times in PBS and incubated in
mild-permeabilisation buffer (PBS, 3% FCS, 0.5% Saponin) for
20 min. Cells were stained with primary monoclonal active
caspase 3 antibody (BD Pharmingen) and with FITC- goat anti
rabbit secondary antibody (Dianova) and measured for FITC+
cells by flow cytometry.
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Cellular fractionation for cytochrome c release assay by
Bim BH3 peptide or IRF3 translocation
Cells were harvested, washed in ice cold PBS, and resuspended
at 16107cells/ml in permeabilisation buffer (20 mM HEPES/
KOH pH 7.5, 100 mM sucrose, 2.5 mM MgCl2, 100 mMKCl,
0.025% digitonin, 16 complete protease inhibitors (Roche)). Cell
membrane permeabilisation was verified by uptake of trypan blue
after incubation on ice for 10 min. Membrane (pellet) and
cytosolic (cytosol) fractions were separated by centrifugation at
13,0006 g for 5 min.
In the case of cytochrome c release assays the pellet fraction was
resuspended in digitonin-free permeabilisation buffer and treated
with Bim BH3 peptide (MRPEIWIAQELRRIGDEFNA ; Bio-
synthan GmbH; HPLC cleanness .90%) for 30 min at 30uC.
Supernatant and membrane (pellet) fractions were separated by
centrifugation (13,0006 g for 5 min). Cytosol, supernatant and
pellet fractions were assessed by Western Blot for cytochrome c,
Bak as a membrane control and F1L as an infection control.
In the case of IRF3 translocation assayspellet fractions were
resuspended in RIPA buffer (Sigma) wit 16 complete protease
inhibitors and prepared along side the cytosol fractions for
Western blotting.
Induction of apoptosis by tetracycline-induced
expression of BimS
MEFs carrying the tetracycline-repressor were generated as
described for HeLa cells [49].
Cells were infected with MVA or MVADF1L for 8 h prior to
addition of tetracycline (0.1 mg/ml) for further 12 h.
MVA-GFP infection of mice
Mice (n = 3) were infected i.v. with 36108 IU of MVA-GFP
for 3 hours before spleens were harvested. Splenocytes were
stained with the following antibodies for phenotypical analysis:
CD11c APC (HL3), CD3 PB(500A2), Gr-1 PE (1A8; all from BD
Pharmingen), CD11b PerCP-C5.5 (M1/70), MHCII eF450 (M5/
114.15.2) and B220 PE (RA3-6B2; all eBioscience).Fluorochrome-
conjugated isotype-matched monoclonal antibodies were used as
controls. Anti- CD16/CD32-Fc-Block (BD Biosciences) was
included. Propidium iodide (Molecular Probes) was added
immediately before analysis for live/dead discrimination. Data
were acquired by FACS analysis on a FACSCanto (BD
Biosciences) and analyzed with FlowJo software (Tree Star, Inc.).
Macrophages (MHC II high /CD11c intermediate / CD11b
high), dendritic cells (MHC II high /CD11c high), B cells (MHC II
high-intermediate /CD45R (B220) high), Granuloytes (Gr-1 high
/ CD11b high) an T cells (CD3+) were identified within GFP+
splenocytes. Similarly, three mice were simultaneously infected i.v.
with 36109 IU of MVA-GFP for 3 hours before spleens were
harvested. Splenocyte preparations were gated for GFP+ cells.
Splenocytes were further assessed for the indicated phenotypical
markers. Macrophages (CD11b+/ Gr12; eBioscience/ BD Phar-
mingen) DC (CD11c; BD Pharmingen) T cells (CD3; BD
Pharmingen), B cells (CD19; BD Pharmingen) and neutrophil
granulocytes (CD11b+/Gr-1+).
Noxa promoter induction
MEFs (wt, IRF12/2, IRF32/272/2, and MAVS2/2) were
seeded at 50,000 cells/well in a six well plate. 24 h later cells were
transfected using Fugene liposomes (Roche) with different reporter
constructs of the Noxa promoter (pGL3-basic plasmid carrying wt
or a double mutant Noxa 1.2 kb promoter region[24]) or pEGFP-
C1 as a transfection control (constructs were kindly provided by
Christophe Lallemand, Villejuif). Twenty-four hours later trans-
fected cells were harvested and in cases when the pEGFP controls
were effectively transfected to values above 20% (EGFP positive
cells were determined by flow cytometry), were split in 96 well
plates at 5,000 cells per well. 16 h post seeding cells were infected
with MVA or MVADF1L for further 8 h. Cells were washed, lysed
in lysis buffer (Promega), and incubated while gently shaking at
37uC for 30 min. Luciferase activity was detected using Orion
MicroplateLuminator (Berthold Detection Systems) and an
luciferase detection buffer (Promega).
IFN-b production
Wt macrophages were seeded at 300,000 cells/well. Twenty-
four hours post seeding cells were infected with MVA or
MVADF1L for 8 h. Supernatant was collected and stored at
280uC. IFN-b was detected using INF-b capture antibody (US
Biological) and anti-mouse INF-b primary detection antibody
(TEBU BIO).
NFkB activity detection
T-REx 293 cells stably carrying a kB promoter luciferase
reporter were seeded at 20,000 cells/well in a 96 well plate.
Twenty-four hours post seeding cells were infected with MVA or
MVADF1L for 8 h and treated with recombinant human IL-1b
(Peprotech) 10 ng/ml for a further 4 h. Luciferase activity was
detected as above.
siRNA transfection of HeLa cells
HeLa cells were seeded at 80,000 cells per well and 24 h later
transfected with LipofectamineRNAiMAX (Invitrogen) as instruct-
ed by the manufacturer. A total of 30 pmoles of siRNA directed
against IFNAR (AACAGCCAUUGAAGAAUCUUC) [50], IRF3
(AACCGCAAAGAAGGGUUGCGU) [50], MAVS (CCAC-
CUUGAUGCCUGUGAA), RIG-I (GUAUCGUGUUAUUG-
GAUUA), MDA-5 (AUCACGGAUUAGCGACAAA), TLR3
(CAGCATCTGTCTTTAATAA) or STING (GCATCAAG-
GATCGGGTTTA) were used in each transfection (these
sequences were kindly provided by Robert Besch, Munich).
Twenty-four after transfection cells were infected with MVA or
MVADF1L for 20 h.
Immunofluorescence microscopy
HeLa cells cells were seeded at 80,000 cells per cover slip
containing well and 24 h later treated with siRNA as above. ER-
HoxB8 macrophages were seeded at 150,000 cells percover slip
containing well. MVA infection was carried out as above for the
desired times of infection. Cells were washed and fixed in 3.7%
formaldehyde prior to permeabilizing with 0.2% Triton-X in PBS.
Cells were washed, blocked in 5%BSA PBS and incubated for
45 min in blocking buffer with a 1:100 dilution of anti-IRF3 (Santa
Cruz Biotechnology). Cells were further washed and incubated in
blocking buffer with a 1:500 dilution of dyelight conjugated anti-
rabbit (Dianova) antibody and 1:15000 dilution of Hoechst dye
(Sigma) for 45 min. Samples were further washed and slides were
mounted. Images were taken with a Zeiss Axioplan 2 Imaging
microscope using the 406magnification lens for all images.
MVA UV treatment
MVA or MVADF1L (36106 IU) were resuspended in 1 ml
DMEM containing 2%FCS and treated with 1 mg/ml of psoralen
(4 -aminomethyl-trioxsalen) and then irradiated with UV for
15 min in a Stratalinker 1800 UV crosslinking unit (Stratagene,
La Jolla, CA, USA).
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MVA total RNA extraction
16106 uninfected or MVA or MVADF1L infected cells (4 hp.i)
were trypsinized and collected for total RNA purification. Isolation
of total RNA was done with the RNeasy Mini Kit (Qiagen) using
QIAshredder (Qiagen) for lysate homogenization as stated in the
manufacturer’s instructions. RNA concentrations collected were in
the range of 150–250 ng/ml and had A260:A280 values of 1.8–2.2.
Total RNA was stored at280uC until used for transfections. Total
RNA was transfected into HeLa cells with Fugene at a ratio of
2 mg RNA and 8 ml Fugene. HeLa cells were simultaneously
transfected with pppRNA (1 mg:8 ml Fugene) or poly(I:C)
(10 mg:8 ml Fugene).
RIG-I and MDA-5 inhibition assays
HeLa cells were transfected with pEF-BOS plasmids containing
FLAG-tagged RIG-I, RIG-I helicase fragment RIG-IC, LGP2 or
pEGFP (transfection control) using Fugene according to the
manufacturers protocol (RIG-I plasmids we kindly provided by
Katharina Eisena¨cher and Anne Krug, Munich). The ratio
Fugene(ml):DNA(mg) was optimized to 8:2.Transfected cells were
infected with MVADF1L for 20 h. Cells were assessed for death or
for FLAG expression. Cells were fixed in 3.7% paraformaldehyde
for 20 min at room temperature, washed three times in PBS and
incubated in mild-permeabilisation buffer (PBS, 3% FCS, 0.5%
saponin) for 30 min. Cells were stained with anti-FLAG M2
mouse monoclonal antibody (Sigma) and goat anti-mouse Alexa
488 labeled secondary antibody (Molecular Probes) and analyzed
by flow cytometry.
Supporting Information
Figure S1 Time course of F1L expression. (A) MEFs were
infected with MVA or MVADF1L at an M.O.I of 10 for 20 h and
the levels of H3L (an MVA membrane protein) and F1L were
assessed by WB. (B) MEFs were treated as in (A) and the levels of
F1L were assessed at the indicated time points by WB.
(PDF)
Figure S2 MVADF1L induced apoptosis is predominantly
mediated by Noxa. (A) MEFs were infected with MVA or
MVADF1L at an M.O.I of 10. Apoptosis was assessed at the
indicated times by PI staining. (B) Samples from Figure 1 (A) were
assessed for cytosolic active caspase-3 20 h.p.i. (C) Samples from
Figure 1 (B,C) were assessed for cytosolic active caspase-3. (D)
Samples from Figure 1 (D) were assessed for apoptosis at time point
20 h.p.i. by PI staining and for cytosolic active caspase-3. Western
blot inserts represent controls for absence of protein expression in
MEFs. (* indicates statistical significance according to the student’s
t-test, p#0.05 with data showing mean/SEM of n$3).
(PDF)
Figure S3 Apoptosis caused by tetracycline inducible Bims
expression in MEFs is only mildly reduced by prior MVA-infection.
(A) wt Tet Bims MVA infected or un-infected (at anM.O.I. of 10 for
8 h) were treated with the indicated concentrations of tetracycline
for 12 h. Cell death was assessed by PI staining. Black box
represents the concentration used for (C). (B) Bims levels from wt
samples from (A) as detected by Western blotting. (C) wt Tet Bims
MEFs were infected with MVA or MVADF1L at an M.O.I. of 10
for 8 h or left uninfected and were treated with tetracycline (0.1 mg/
ml) for 12 h. Apoptosis was assessed by detection of cytosolic active
caspase-3 (data are mean/SEM of n$3).
(PDF)
Figure S4 Infection pattern in primary cells upon infection of
mice with high-dose MVA. Three mice were in one experiment
infected i.v. with 36109 IU of MVA-GFP 3 h before spleens were
harvested. Splenocyte preparations were stained for the markers
shown and gated for GFP+ cells for analysis. MVA preferentially
infects dendritic cells (CD11c+, second panel from top) and
macrophages (CD11b+/Gr12, bottom). Infection rates of T cells,
B cells and granulocytes (CD3, CD19 and CD11b+/Gr-1+) were
lower. Each column shows data from one mouse.
(PDF)
Figure S5 While MVA induced apoptosis is predominantly
induced by Noxa, Bim does synergize with Noxa to induce
apoptosis in the primary infection target cells of MVA. (A)Samples
from Figure 4 were assessed for cytosolic active caspase-3. Active
caspase-3 relative numbers were calculated by calculating the %
increase in active caspase-3 positive cells proportional to the
untreated sample with the following equation: (((% Treated active
caspase 3+)2(%untreated active caspase 3+))/(1002% untreated
active caspase 3+))*100). (* indicates statistical significance according
to the student’s t-test, p#0.05 n$3). (B) B220+MACS sorted B-cells
and NK1.12/B2202/MHCII2MACS sorted T-cells were infected
withMVA orMVADF1L at anM.O.I of 10 for 48 h. Apoptosis was
assessed by PI staining and relative numbers were calculated as in
Figure 4. (* indicates statistical significance according to the
student’s t-test, p#0.05 with data showing mean/SEM of n$3).
(PDF)
Figure S6 Cell death of hematopoietic cells in culture upon viral
infection. (A) The same cellular subsets from Figure 4 were
assessed by PI staining at the indicated times with or without
infection with MVA or MVADF1L (n= 3). (B) Macrophages from
Figure 5(A) were assessed by PI staining with or without infection
with MVA or MVADF1L (n = 3). Values represent raw values
obtained from three independent experiments without compen-
sating for the simultaneous death of cells in the untreated samples.
(PDF)
Figure S7 Effect of RNAi to Bim, Noxa and Puma on death
during infection of HeLa cells with MVADF1L. (A) HeLa cells
were infected with MVA or MVADF1L at an M.O.I of 10 for the
indicated times. Cell death was assessed by PI staining (n$3). (B)
HeLa cells were transfected with the indicated siRNA 24 h prior
to infection with MVADF1L at an M.O.I of 10 for 20 h. Noxa and
Bim levels were assessed before (far right lane) and after infection
(all other lanes) (n = 2). (C) Cells from (B) were assessed for
apoptosis by detecting cytosolic active caspase-3 (means from n= 2
independent experiments). (* indicates statistical significance
according to the student’s t-test, p#0.05 n values indicated).
(PDF)
Figure S8 p53,MyD88 and the inflammasome are not required for
Noxa mediated apoptosis even though INF-b is produced. (A) M-
CSF bone marrow derived macrophages were infected with MVA or
MVADF1L at anM.O.I of 10 for 20 h. Cell death was assessed by PI
staining (means from two independent experiments) (B) IFN-b
concentrations were measured by ELISA in supernatants of wt M-
CSF bone marrow derived macrophages uninfected or infected with
MVA or MVADF1L at an M.O.I of 10 for 8 h (n=3). (C) wt MEFs
were infected with MVA or MVADF1L at an M.O.I of 10 for the
indicated times. Samples were assessed for IL-18 expression by WB
(n=3). (D) M-CSF bone marrow derived macrophages were treated
as in A (n=3). (* indicates statistical significance according to the
student’s t-test, p#0.05 n-values indicated).
(PDF)
Figure S9 IRF3 translocates to the nucleus in response to MVA
infection independently of IFNAR. (A) HeLa cells were transfected
with the indicated siRNA 24 h prior to infection with MVA or
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MVADF1L (MOI= 10) for the indicated times. Cells were then
fixed and stained with antibody against IRF3 and with Hoechst.
The images are representative of the general cellular population at
the indicated time points post infection (n= 2). (B) Percentage of
cells with nuclear IRF3 were calculated by counting cells in 6
different microscopic fields for each time point and dividing the
number of cells with nuclear IRF3 by the total number of cells in
the field of view. Data are means of two independent experiments
(C) siRNA against IFNAR was functional as it was able to inhibit
MVADF1L induced apoptosis when cells were infected at an MOI
of 10 for 20 h. (D) HeLa cells treated as in (A) were collected at the
indicated times, digitonin (0.025% w/v) permeabilized and
fractionated into cytosolic and total membrane fractions. IRF3
localization was assessed by Western blot. C is the cytosolic
fraction released upon cellular membrane permeabilization. P
represents the pellet fraction including nucleus, cellular membrane
and intact mitochondria. (E) wt and IFNAR2/2 ER-HoxB8
immortalized macrophages were infected with MVA or
MVADF1L at an MOI of 10 for the indicated time points after
7 days differentiation in GM-CSF medium deficient in b-estridiol,
and IRF3-translocation was determined as in (D).
(PDF)
Figure S10 LGP2 can act as a dominant negative inhibitor of
MVADF1L induced apoptosis. (A) pEF-BOS plasmids containing
the indicated FLAG-tagged proteins or pEGFP (transfection
control) were transfected into HeLa cells. After 24 h cells were
infected with MVA or MVADF1L at an M.O.I of 10 for 20 h. Cell
death was assessed by PI staining and relative numbers were
calculated as in Figure 4 (n= 3). (B) Samples from A were stained
for intracellular FLAG before and after infection with MVADF1L
at an M.O.I of 10 for 20 h (n= 2).
(PDF)
Figure S11 Full viral RNA induced apoptosis requires RNA
helicase dependent induction of Noxa. (A) HeLa cells were
transfected with the indicated siRNA 24 h prior to transfection of
total RNA from HeLa cells infected with MVA or uninfected
HeLa cells using Fugene reagent. Cell death was assessed 24 h
later by PI staining and relative numbers were calculated by
calculating the % increase in PI proportional to the Fugene-alone
treated sample as in Figure 7 (with data showing mean/SEM of
n$3). (B) Hela cells stably expressing shRNA specific to Luciferase
(control) and Noxa were transfected with total RNA from HeLa
cells infected with MVA or uninfected HeLa cells using Fugene
reagent; or infected with MVA or MVADF1L. Cell death was
assessed 24 h later by PI staining and relative numbers were
calculated by calculating the % increase in PI proportional to the
Fugene-alone treated sample as in Figure 7. In the case of infection
with MVA or MVADF1L relative values were calculated as in
Figure 4 (with data showing mean/SEM of n= 3). shRNA
efficiency was assessed by Western Blot (right hand panel) (*
indicates statistical significance according to the student’s t-test,
p#0.05 with data indicating mean/SEM of n$3; x indicates
unspecific band).
(PDF)
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